Suchergebnisse - "Osimertinib"

PubPharm (2.543)

1

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations : Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

enthalten in: JCO precision oncology | 2024

von Chen, M. | Song, Z. | Yu, H. | +19

2

Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer

enthalten in: Cancer letters | 2024

von Han, R. | Lin, C. | Lu, C. | +10

3

Assessing EGFR-mutated NSCLC with bone metastasis : Clinical features and optimal treatment strategy

enthalten in: Cancer medicine | 2024

von Chen, W. | Cheng, W. | Chen, C. | +6

4

Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer

enthalten in: Biochemical pharmacology | 2024

von Cao, L. | Qin, Z. | Yu, T. | +6

5

Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancer

enthalten in: Communications biology | 2024

von Pfeifer, M. | Brammeld, J. | Price, S. | +25

6

Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

enthalten in: BMC medicine | 2024

von Han, R. | Guo, H. | Shi, J. | +8

7

Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

enthalten in: BMC medicine | 2024

von Han, R. | Guo, H. | Shi, J. | +8

8

Simultaneous Quantitation of Anlotinib and Osimertinib by Isotope-Labeled UHPLC-MS/MS in Human Plasma : Application in NSCLC Patients

enthalten in: Journal of chromatographic science | 2024

von Liu, Y. | Lin, Z. | Luo, W. | +6

9

Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Remon, J. | Besse, B. | Aix, S. | +19

10

Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer

enthalten in: JTO clinical and research reports | 2024

von Tozuka, T. | Noro, R. | Yoshida, K. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[255]